We are live on
!
Find out more
JF
Jump Financial Portfolio holdings
AUM
$7.5B
1-Year Est. Return
33.9%
This Fund
S&P 500
This Quarter
Est. Return
+5.93%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
–
AUM
$2.71B
AUM Growth
+$256M
(+10%)
Cap. Flow
+$184M
Cap. Flow
% of AUM
6.78%
Top 10 Holdings %
Top 10 Hldgs %
6.67%
Holding
2,298
New
784
Increased
473
Reduced
488
Closed
552
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$19.5M |
| 2 |
Target
TGT
|
+$17.3M |
| 3 |
Royalty Pharma
RPRX
|
+$15.5M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$14.9M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$12.2M |
| 2 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$11M |
| 3 |
iShares Semiconductor ETF
SOXX
|
+$10.4M |
| 4 |
ProShares UltraPro Short QQQ
SQQQ
|
+$8.83M |
| 5 |
ProShares UltraPro S&P 500
UPRO
|
+$8.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.61% |
| 2 | Industrials | 13.75% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Discretionary | 12.54% |
| 5 | Financials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVTA
1601
DELISTED
Invitae Corporation
NVTA
| $136K | 0.01% |
120,776
+18,412
| +18% | +$23.2K |
|
1602
ASE Group
ASX
$76.3B
| $134K | ﹤0.01% |
17,206
-305,394
| -95% | -$2.35M |
|
1603
PagSeguro Digital
PAGS
$2.75B
| $134K | ﹤0.01% |
14,197
-450,153
| -97% | -$4.56M |
|
|
DSEY
1604
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $134K | ﹤0.01% |
+15,954
| New | +$132K |
|
|
DVAX
1605
DELISTED
Dynavax Technologies
DVAX
| $134K | ﹤0.01% |
10,339
-96,402
| -90% | -$1.1M |
|
1606
Anavex Life Sciences
AVXL
$250M
| $133K | ﹤0.01% |
16,368
-6,632
| -29% | -$56.8K |
|
1607
LSB Industries
LXU
$794M
| $132K | ﹤0.01% |
13,384
-344
| -3% | -$3.29K |
|
1608
Tenaya Therapeutics
TNYA
$163M
| $131K | ﹤0.01% |
+22,300
| New | +$130K |
|
|
MAGN
1609
Magnera Corp
MAGN
$475M
| $131K | ﹤0.01% |
3,325
-1,406
| -30% | -$63.7K |
|
|
SLCA
1610
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $131K | ﹤0.01% |
10,760
-27,442
| -72% | -$339K |
|
1611
Compañía de Minas Buenaventura
BVN
$8.09B
| $130K | ﹤0.01% |
17,700
-35,100
| -66% | -$259K |
|
1612
Pennant Group
PNTG
$1.43B
| $130K | ﹤0.01% |
10,567
-19,312
| -65% | -$246K |
|
|
DADA
1613
DELISTED
Dada Nexus
DADA
| $129K | ﹤0.01% |
+24,257
| New | +$147K |
|
1614
Janux Therapeutics
JANX
$950M
| $128K | ﹤0.01% |
+10,821
| New | +$145K |
|
1615
Runway Growth Finance
RWAY
$234M
| $128K | ﹤0.01% |
10,400
-24,702
| -70% | -$287K |
|
|
INZY
1616
DELISTED
Inozyme Pharma
INZY
| $127K | ﹤0.01% |
+22,800
| New | +$135K |
|
1617
Ambev
ABEV
$48.2B
| $126K | ﹤0.01% |
+39,550
| New | +$116K |
|
|
PLYA
1618
DELISTED
Playa Hotels & Resorts
PLYA
| $125K | ﹤0.01% |
+15,321
| New | +$139K |
|
1619
Crescent Energy
CRGY
$3.69B
| $125K | ﹤0.01% |
+11,960
| New | +$128K |
|
1620
Actinium Pharmaceuticals
ATNM
$26.3M
| $124K | ﹤0.01% |
16,700
+3,608
| +28% | +$30.7K |
|
|
HYPD
1621
Hyperion DeFi Inc
HYPD
$40.3M
| $123K | ﹤0.01% |
+650
| New | +$186K |
|
1622
Oric Pharmaceuticals
ORIC
$1.2B
| $122K | ﹤0.01% |
15,700
-8,649
| -36% | -$49.1K |
|
|
ETRN
1623
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $122K | ﹤0.01% |
12,742
-53,495
| -81% | -$359K |
|
1624
Caesarstone
CSTE
$71.6M
| $122K | ﹤0.01% |
23,204
+804
| +4% | +$3.64K |
|
1625
Clean Energy Fuels
CLNE
$425M
| $121K | ﹤0.01% |
24,465
-266,602
| -92% | -$1.17M |
|
Similar funds
YAM
ASN
SP
AMH
BIM
CCM
GJL
DKCM
Jump Financial's Q2 2023 Portfolio in Review
As of Q2 2023, Jump Financial held 2,298 positions worth $2.71B, up 10% from $2.46B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Jump Financial deployed $184M of net new capital in Q2 2023, opening 784 new positions and adding to 473 existing holdings. Its largest new stake was Royalty Pharma: 456,285 shares worth $14M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $12.2M trimmed.
- Jump Financial's largest Q2 2023 buy was Royalty Pharma: 456,285 shares worth $14M.
- Jump Financial added most to State Street Utilities Select Sector SPDR ETF in Q2 2023, an estimated $19.5M increase.
- Jump Financial's biggest Q2 2023 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $12.2M.
- Jump Financial fully exited ProShares Short VIX Short-Term Futures ETF in Q2 2023, selling an estimated $11M.
- Jump Financial's ten largest holdings make up 6.7% of its $2.71B portfolio in Q2 2023.
- Jump Financial opened 784 new positions and closed 552 in Q2 2023.
- Jump Financial's portfolio value rose 10% quarter-over-quarter to $2.71B.
Based on Jump Financial's 13F filing for Q2 2023, filed 7 Aug 2023.